Background: Existing treatments for depression are known to have only modest effects, are insufficiently targeted, and are inconsistently utilized, particularly in older adults. Indeed, older adults with impaired cognitive control networks tend to demonstrate poor response to a majority of existing depression interventions. Cognitive control interventions delivered using entertainment software have the potential to not only target the underlying cerebral dysfunction associated with depression, but to do so in a manner that is engaging and engenders adherence to treatment protocol.
INTRODUCTION
Despite decades of research into the treatment of depression, this disorder has been the second leading cause of global disability for the last 10 years (Ferrari et al., 2013) . Underlying causes for this public health problem are the modest effects of existing treatments, their limited accessibility and quality when delivered in routine practice, and
Abbreviations: HAM-D, Hamilton Depression Rating Scale; LLD, late life depression; PHQ, Patient Health Questionnaire; PST, problem solving therapy; TOVA, test of variables of attention; WHODAS, World Health Organization disability assessment schedule the high rate of early treatment discontinuation for both psychotherapies and medications (Mulder, Frampton, Luty, & Joyce, 2009; Thase et al., 1992; Warden et al., 2014) . According to the National Institute of Mental Health (NIMH), this problem is due to the fact that existing treatments only manage symptoms rather than treat to the underlying causes of depression (Insel & Wang, 2009) . In response to this problem, the most recent NIMH strategic plan calls for the development of novel interventions that treat the known cognitive and behavioral correlates of depression (NIMH, 2015) . The plan additionally calls for the development of interventions that are portable and accessible to the general public, in order to mitigate the 20-to 30-year gap commonly found between discovery and implementation (NIMH, 2016) . In summary, to reduce the burden of depression, we need to develop interventions that are both targeted to underlying causes of depression symptoms and that are easily deployed into the community.
Cognitive control deficits and late life depression
Although there is still much to learn about the causes of depression, one area that has been well studied is late life depression (LLD), major depression that occurs after the age of 65. Research has repeatedly demonstrated that older adults with deficits in cognitive control functions have a poor response to antidepressant medications (Alexopoulos, 2001; Alexopoulos, Kiosses, Klimstra, Kalayam, & Bruce, 2002; Kiosses, Klimstra, Murphy, & Alexopoulos, 2001; Manning et al., 2015; Morimoto et al., 2011) and some forms of psychotherapy (Thompson et al., 2015) . The relationship of cognitive control dysfunction in older adults to poor antidepressants is supported by structural MRI, focal cerebral activation, and functional connectivity studies (Alexopoulos et al., 2012 (Alexopoulos et al., , 2013 Bredemeier et al., 2012; Gunning-Dixon et al., 2010; Gunning-Dixon, Brickman, Cheng, & Alexopoulos, 2009; Joormann & Gotlib, 2010; Kaiser, Andrews-Hanna, Wager, & Pizzagalli, 2015; Sheline, Price, Yan, & Mintun, 2010) . A key deficit of cognitive control in LLD is difficulty ignoring irrelevant, especially negatively biased information. This difficulty impacts the depressed individual's ability to attend to information central to goal-directed behavior. Cognitive control is particularly vulnerable to advancing age (Davis, Dennis, Daselaar, Fleck, & Cabeza, 2008; Gunning-Dixon & Raz, 2003; GunningDixon et al., 2009; Nielson, Langenecker & Garavan, 2002) and at least 40% of older adults with depression suffer from cognitive control dysfunction (Lockwood, Alexopoulos, & van Gorp, 2002) . Poor functioning of cognitive control networks in late life is characterized by increased susceptibility to interference from task irrelevant stimulus properties, poor response inhibition, and reduced sustained attention (Alexopoulos et al., 2005; Alexopoulos, Gunning-Dixon, Latoussakis, Kanellopoulos, & Murphy, 2008; Manning et al., 2015) .
Treating LLD characterized by cognitive control deficits
Preliminary evidence suggests that behavioral interventions that reinforce and enhance behaviors associated with cognitive control may be effective for LLD characterized by these deficits. In our own work with problem solving therapy (PST), an intervention that helps patients with goal-directed behavior, we have found that people with this presentation of LLD benefit significantly from PST, demonstrating very large effect sizes (NNT = 4 ). However, a primary limitation with this intervention and those like it, is that PST is hardly ubiquitous, and as has been detailed in a recent IOM report regarding the quality of psychotherapy, the chance that an intervention like PST is both available and delivered with high quality is very low (NAS, 2015) .
An alternative approach to treating patients with LLD with such deficits is through computerized cognitive control interventions. An advantage to treatment using video game technologies is that they can be (1) standardized, and as result are not subject to the skill drift seen in the delivery of other behavioral interventions, (2) personalized in that they are set to the baseline functioning of the individual and adapt as the individual improves, and (3) are easily accessed and can be delivered in the individual's home, minimizing typical access barriers older adults contend with when accessing traditionally delivered mental health care (Anguera & Gazzaley, 2015; Mishra, Anguera, & Gazzaley, 2016) . The utilization of these types of tools is especially prevalent amongst older adults, with one-third of people over 65 using digitally based cognitive exercises currently (Allaire et al., 2013) .
Future digital health use is predicted to increase substantially as the baby-boomer generation ages (Collier, 2014) , which could lead to a new avenue for providing mental health treatment.
Recent reports indicate that commercial interventions are not evidence based (Hamilton, 2009) , and that the impact these interventions have on function is limited because they do not specifically target a known underlying mechanism, nor do they thoroughly challenge the brain enough to confer positive effects on behavior. Some studies have
shown that older adults demonstrate marked improvement in cognitive control abilities following directed interventions that specifically target cognitive control deficits (Anguera et al., 2013; Berry et al., 2010; Mishra, de Villers-Sidani, Merzenich, & Gazzaley, 2014) . Recent work by Anguera et al. (2013) demonstrated that a video game targeting cognitive control abilities enhanced deficient age-related cognitive control processes, the very processes that are implicated in LLD . If a video game designed to target cognitive control deficits could improve cognitive control functions in older adults with LLD, it might be able to improve depression in this population.
In this proof-of-concept study, our exploratory hypotheses were (1) to explore the impact of a cognitive control intervention embedded into an entertainment software platform on cognitive control network, mood and disability in people with LLD, and compare the findings to patients who received PST; (2) to explore the association of cognitive control network activation (as measured by behavioral assessment) on mood and functional disability, and finally (3) determine the acceptability of such a cognitive control intervention for depressed individuals.
METHODS

Design
This was a proof-of-concept randomized clinical trial (Clinicaltrials.gov #NCT02229188) with 22 community-based participants over the age of 65 suffering from major depression. Proof-of-concept studies are widely used as a first step in human trials, most commonly in cancer trials, where a novel compound is tested in a small sample of participants to determine whether there is an effect on the underlying dynamics of a disease state, as well as an impact on a clinical outcome. The intent of these studies is to identify promising candidate interventions for larger scale study (Banerji & Workman, 2016; Kendig, 2016) . Using a random number generator, participants were randomized to receive 8 weeks of PST alone or 4 weeks of a cognitive intervention (Project: EVO TM ) + 4 weeks of clinical management. Participants were assessed 
Eligibility
To determine the presence of Major Depression Disorder (MDD) and exclusion diagnosis, we administered the Structured Clinical Interview for DSM Disorders (SCID; DSM-IV version) (First, 2015) . Eligible participants met the following criteria: (1) must be 60 years old or older, (2) met criteria for Major Depression as defined by the SCID and Patient Health Questionnaire (PHQ-9), in addition to having a Hamilton Depression Rating Scale (HAM-D) score >24, 2 weeks following this initial screening, (3) an MMSE of at least 24 or above, (4) spoke and read English at a 6th grade or better level, and (5) was able to physically participate in a research protocol (e.g. were not suffering from a terminal or highly disabling illness). Exclusion criteria included: (1) history of psychosis, mania, or are currently using or abusing illicit drugs or alcohol, (2) diagnosis of dementia, or (3) a clinical diagnosis of dementia by DSM-IV (see Fig. 1 for more details on inclusion/exclusion criteria). The current use of any antidepressant medication did not act as an exclusionary criterion. Although we recognize that this will be a conservative estimate, we have used this cut-score successfully in other clinical trials and have not observed differential recruitment of people with lower educations or who are racial/ethnic minorities. Participants were reimbursed $75.00 for assessments. Randomization to each treatment protocol was determined with a random number generator. Participants were randomized after they were found to be eligible for participation and had given consent to participate.
Intervention training and adherence
Clinicians were assigned to deliver one of the two conditions. All clinicians were trained in their respective interventions during a didactic workshop about the therapeutic rationale of the intervention and the therapeutic process. They then practiced therapy sessions through guided role-play training. All treatment sessions were recorded and rated by independent experts for treatment fidelity and adherence.
Problem solving therapy
Problem solving therapy (PST) is an 8-week intervention that consists of three treatment phases: phase one lasting 3 weeks is psychoeducational, helping participants understand the problem solving steps and using the problem solving action planner for working on psychosocial problems; phase two consists of independent practice of the PST skills; phase three consists of two relapse preventions sessions, using the problem solving model to develop plans to maintain depression and functional treatment gains. Although this is a 8-week intervention, positive effects for PST are evident as early as 4 weeks (Arean, Hegel, Vannoy, Fan, & Unuzter, 2008) . PST itself consists of a seven-step process to solve problems. These include problem orientation that directs patient attention to one problem at a time, problem definition that helps patients select our relevant information to determine what the root problem is in a given situation, goal setting that focuses attention to the desired outcome, brainstorming that helps patients consider multiple methods for reaching the goal, decision making, a method employed to evaluate the alternative solutions likelihood of reaching the stated goal and picking the best solution among the choices, and action planning that involves a step-by-step plan for the patient to implement his/her solution.
Cognitive intervention
The cognitive intervention in this study is a mobile, iPad intervention ipants did check in with their therapist 1×/week regardless of which group they were in. However, EVO participants were simply asked about their experience and reviewed their progress with their therapist and were not given any additional treatment during these sessions.
Clinical outcome measures
Depression symptoms were measured using HAM-D (our primary mental health outcome measure) and the PHQ-9 (our secondary mental health outcome measure) (Kroenke, Spitzer, & Williams, 2003) .
Note that the PHQ-9 was first administered during the screening process, with the HAM-D administered 2 weeks after screening. Physical disability was assessed through the Charleston Comorbidity Index (Charlson, Pompei, Ales, & MacKenzie, 1987) and WHODAS (1999) .
Research assistants who were trained and supervised by the program manager collected these measures. Interrater reliability was calculated on a monthly basis with an effort to keep ICC to .90 or better. Corrective retraining was available to any assistant whose administration or scoring of any instrument falls below this standard, however, none fell below the standard.
Cognitive outcome measures
The cognitive outcome measures involved tasks assessing different cognitive control domains: sustained attention (test of variables of attention, TOVA (Greenberg, 1996) ) and working memory (a delayedrecognition task (Clapp, Rubens, Sabharwal, & Gazzaley, 2011) ipant which task conditions they will be performing for the duration of that run. In the "ignore distractor" (ID) condition, participants are instructed to ignore the distracting face stimulus while maintaining the representation of the cue face. In the "no distractor" (ND) condition, participants simply perform the WM task. TOVA is a sustained attention task that requires participants to respond to rarely occurring stimuli while ignoring all others, and has been used as a outcome measure in our previous work (Anguera et al., 2013) . Finally, participants performed a basic response time task at each outcome measure testing session to confirm that any response time improvements are not solely due to heightened motoric changes, as evidenced through the absence of a change in performance over time on this test.
Negativity bias/negative self-referential processing
Participants completed a trait adjective task to assess negativity bias (Harmer et al., 2009) . During the task, participants viewed a list of adjectives one at a time that described positive and negative personality characteristics. Participants were instructed to quickly indicate whether each of these adjectives applied to them by pressing one of two response keys. Positive and negative adjectives were selected from a normed word list and matched for word length, frequency, and arousal. The degree of desirability of positive words was comparable to the degree of undesirability of negative words (Anderson, 1968) . Stim- 
F I G U R E 2
Change in depressive symptoms over time. Both the EVO and PST groups showed a comparable improvement in depressive symptoms (as measured through the Hamilton Depression Rating Scale) over the course of treatment (4 weeks), with these improvements persisting to the 8-week mark. * P < .05
F I G U R E 3 Cognitive control transfer effects. (A)
Performance on the delayed-recognition working memory task: EVO participants showed a significant improvement beyond the PST group on a RT measure of working memory in the presence of distraction and (B) no distraction. (C) Performance on the sustained attention task (TOVA): EVO participants showed a significant improvement beyond the PST group on a RT measure of sustained attention. * P < .05
Data analysis
To isolate those measures that changed significantly following training we performed session × study-group ANOVAs. We also performed a repeated measures within-factor post-hoc power analysis (completed using G*Power (Faul, Erdfelder, Buchner, & Lang, 2009 )) designed to reveal an effect specifically in the EVO group associated with improvements in depressive symptoms as measured by the HAM-D across the three measured time points. We also present the F-value associated with the ANCOVAs for each measure in Supporting Information values reported for the clinical outcomes were calculated using Cohen's d (1988) and corrected for small sample bias using the Hedges and Olkin approach (Hedges & Olkin, 1985) .
RESULTS
Demographics
Twenty two participants (68 years of age ± 6.3; 16 females) were randomly assigned to either the EVO or PST groups (see Fig. 1 ). Note that the majority of people screened did not qualify because they (1) did not have major depression (2) were not willing to be randomized, and (3) 
Participant retention and training adherence
Participants in the PST group completed all of their scheduled visits with their therapists across the 8-week period. Participants in the EVO group showed remarkable compliance with respect to game play, with participants demonstrating a 100% rate of compliance. One participant elected to drop out of the study (PST cohort) during our baseline assessment. In addition, some participants were not able to complete certain testing due to fatigue or complications during their visits to clinic, leading to differential number of participants for some of the subsequent analyses below (as seen in the reported degrees of freedom).
Clinical outcomes
The mean MMSE score for participating individuals at baseline was 28.9, with a mean Hamilton-D score of 22.6 (±3.5) and PHQ-9 of 14.1 (±3.9). Group (Warden et al., 2014 Using the same ANOVA and follow-up approach as above, an assessment of disability through the WHODAS-II test failed to reveal a group X session interaction (F(2,32) = .67, P = .52). However, a linear contrast of session was significant (F(1,16) = 13.1, P = .002), indicating a significant change in reported disability across time. Follow-up testing revealed that while there was no group difference at any time point (P > .40 in each case), the EVO group showed a trend (P = .058, Cohen's d = .56) toward a significant improvement from baseline to the 4-week mark compared to the PST group (P = .84, Cohen's d = .07).
Behavioral outcomes-negativity bias/negative self-referential processing
Negativity bias was examined through the trait adjectives task at baseline, week 4, and week 8 via the number of endorsed positive self-descriptors and unendorsed/rejected negative self-descriptors (and response times for each). The trait adjective task was modeled after that used by Harmer et al. (2009) . A repeated measure ANOVA for the number of unendorsed negative self-descriptors revealed a significant effect of time (F(2,28) = 3.58, P = .041) and a significant group × time interaction (F(2,28) = 3.60, P = .040), suggesting EVO participants experienced a differential decline in negativity bias over time compared to the PST participants. Follow-up contrasts revealed that while no group differences were present at either baseline or week 4 (T ≤ .17, P ≥ .86, respectively), a group difference was present at week 8 (T = 2.29, P = .035) indicative of the EVO participants showing more rejected negative self-descriptors than the PST group after the treatment period (see Table 2 ). Of note, the group difference in change in negativity bias may have been related to a failure of the PST group to sustain a decrease in negativity bias from week 
Behavioral outcomes-cognitive control measures
The EVO group showed improved performance on two untrained cognitive control tasks that have previously shown selective improvements in older adults participating in interference training (Anguera et al., 2013) . More specifically, ANOVAs revealed group × session interactions indicative of selective improvements for the EVO group during a delayed-recognition working memory task (Clapp et al., 2011) in the setting of distraction (F(1,16) = 8.10, P = .012) and without distraction (F(1,16) = 6.15, P = .025), as well as a standard test of sustained attention (Greenberg, 1996) (F(1,16) = 10.11, P = .005; see Table 3 ). Planned comparisons showed that following training, the EVO group exhibited significantly faster responses to memory probes in the delayed recognition task, both with (Fig. 3A ) and without distraction (Fig. 3B ), and to rare target stimuli in the TOVA ( Fig. 3C ; P < .01 in each case), with no improvements observed in the PST group (P > .50 in each case). These cognitive improvements were specific to working memory and sustained attention processes and not the result of a generalized increase in reaction time, as a group × session interaction was not present on a basic stimulus detection task (F(1,17) = 0.19, P = .67), and neither group showed a significant improvement across time on this measure (P > .60 for each group).
In follow-up analyses, we compared these results to previously published findings by Anguera et al. (2013) where healthy older adults were tested on these same measures (see Supporting Information
Figs. 2 and 3). No group differences were present between the EVOtreated individuals and those in the NeuroRacer group on any of the transfer measures (P < .40 in each case), suggesting a comparable improvement was observed in cognitive control function using EVO as with NeuroRacer.
DISCUSSION
To our knowledge this is the first study to compare a targeted video game intervention designed to address deficient cognitive control to a gold standard psychotherapy for LLD characterized by cognitive control deficits. Our findings provide preliminary evidence that a video game intervention targeting the cognitive control network is a potentially effective intervention for both mood and cognitive symptoms of LLD, and that the effects on mood and disability are comparable to a therapeutic gold standard and to what has been demonstrated in the literature . The benefits of this intervention over traditional treatments such as antidepressant medication and psychotherapy, is its ease of use, its portability, and its ability to improve cognitive symptoms. We additionally found the cognitive con- that these approaches have only inconsistent effects on cognition (Motter et al., 2016) , with the effect of such training on cognition appearing to decline slightly with age. We observed here that the EVO-trained older adult participants did indeed experience cognitive control enhancements beyond any basic motoric improvements in response time. Thus, these transfer effects are indicative that a properly designed intervention that challenges specific neural circuitry can have beneficial effects in an older population suffering from depression.
The EVO transfer effects also suggest that the improvements in depressive symptoms may have been driven by distinct underlying mechanisms of action associated with cognitive control. EVO appears to challenge similar cognitive control networks as those reported by Anguera et al. (2013) in healthy older adults who played a similar game for 1 month. In that study, the improvements in cognitive control were associated with heightened activity at the prefrontal cortex in the form of midline frontal theta, as measured through electroencephalography (EEG). This marker is of particular interest given its association with one's response to antidepression medication (Mulert et al., 2007) , and that the underlying brain region thought to be generating this signal, the anterior cingulate cortex, plays a critical role in models of depression (Pizzagalli et al., 2001; Pizzagalli, Oakes, & Davidson, 2003) , particularly in response to treatment . Thus these findings suggest that the improved depressive symptoms in EVO may be spurred on plasticity-based changes in cognitive control networks.
The EVO group demonstrated a decline in negativity bias that continued after the end of treatment, which was not evident in the PST group. From an affective neuroscience perspective, we believe a continued decline in negativity bias/negative self-referential processing may reflect a change over time in the interaction of the cognitive control system with the functioning of other systems involved in negative self-referential processing (e.g., the default mode network). However, the basis of this interpretation would require evaluation in a larger sample and using additional measures of the cognitive control network and other networks believed to be key to the expression of depression.
We recognize that this proof-of-concept study involves a small sample size, and was clearly not powered to be a noninferiority study.
Although our numbers are equal to more than half of those reported by Motter et al. (2016) , the generalizability of the findings are limited and these initial results will clearly require replication in a larger cohort.
Indeed, the goal of this study was not to differentiate the efficacy of the two approaches used here, but to observe whether they were comparable within a similar time period of treatment. Our sample sizes are sufficient to determine the feasibility of the trial, and to pass a proofof-concept phase, but are too small to make firm conclusions about the impact of EVO on cognitive control network functions, negativity bias, depression, and disability outcomes. Subsequent work that interrogates the efficacy of different dosages is also warranted, as similar approaches with treatments (such as PST However, we do not believe this is the case here: we used a similar screening protocol in our previous work , ensuring comparable standards between this work. More importantly, PST has already been shown to produce effects greater than a supportive therapy control in numerous studies with depressed older adults Alexopoulos, Raue, & Arean, 2003; Alexopoulos, Raue, Kanellopoulos, Mackin, & Arean, 2008; Arean et al., 1993 Arean et al., , 2008 Arean et al., , 2015 Chu, Huynh, & Arean, 2012; Crabb, Arean, & Hegel, 2012; Gustavson et al., 2016; Mackin et al., 2014; Mackin, Arean, & Elite-Marcandonatou, 2006; Sharpe et al., 2012) . Although, we cannot claim that EVO is not significantly worse than PST, we did find the effect sizes for EVO are similar to those found in the literature and is thus worth further study as a depression intervention.
Subsequent work that interrogates the neural correlates of each type of treatment would supplement these findings by highlighting the differential behavioral effects with neural activity measures, and how these patterns of activity relate to each group. If these initial pilot findings are confirmed in larger randomized controlled trials, the use of targeted digital platforms may represent a novel therapeutic advance for the treatment of depression in a population that is notoriously underserved and susceptible to poor response to traditional depression intervention.
